Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Don J Diamond

Showing results (71-80 of 134) with videos related to

Pageof 14
Sort By:
The Journal of Infectious Diseases|April 15, 2020
Chimeric Antigen Receptors Targeting Human CytomegalovirusAyub Ali, Flavia Chiuppesi, Minh Nguyen, et al.
Plos One|August 17, 2017
Comparison of homologous and heterologous prime-boost vaccine approaches using Modified Vaccinia Ankara and soluble protein to induce neutralizing antibodies by the human cytomegalovirus pentamer complex in miceFlavia Chiuppesi, Felix Wussow, Louise Scharf, et al.
Cancer Gene Therapy|March 3, 2019
Salmonella-mediated therapy targeting indoleamine 2, 3-dioxygenase 1 (IDO) activates innate immunity and mitigates colorectal cancer growthThuy Phan, Vu H Nguyen, Marcela S D'Alincourt, et al.
Medical Microbiology and Immunology|January 16, 2008
Evaluation of recombinant modified vaccinia Ankara virus-based rhesus cytomegalovirus vaccines in rhesus macaquesYujuan Yue, Zhongde Wang, Kristina Abel, et al.
Vaccine|June 17, 2015
Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortalityElizabeth C Swanson, Pete Gillis, Nelmary Hernandez-Alvarado, et al.
Cancer Research|April 30, 2011
Enhancement of cancer vaccine therapy by systemic delivery of a tumor-targeting Salmonella-based STAT3 shRNA suppresses the growth of established melanoma tumorsEdwin R Manuel, Céline A Blache, Rebecca Paquette, et al.
Transplantation and Cellular Therapy|March 10, 2022
CMV Triplex Vaccine to Enhance Adaptive NK and T-cell Reconstitution After Autologous Hematopoietic Cell TransplantationArmin Rashidi, Corinna La Rosa, Julie Curtsinger, et al.
The Journal of Infectious Diseases|February 18, 2005
Simultaneous reconstitution of multiple cytomegalovirus-specific CD8+ cell populations with divergent functionality in hematopoietic stem-cell transplant recipientsSimon F Lacey, Joy Martinez, Ghislaine Gallez-Hawkins, et al.
Journal of Virology|November 15, 2019
Correction for Chiuppesi et al., "Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Responses against Human Cytomegalovirus in Mice"Flavia Chiuppesi, Jenny Nguyen, Soojin Park, et al.
Journal of Virology|July 27, 2018
Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in MiceFlavia Chiuppesi, Jenny Nguyen, Soojin Park, et al.
Pageof 14

Showing results (71-80 of 134) with videos related to

Sort By:
Pageof 14
The Journal of Infectious Diseases|April 15, 2020
Chimeric Antigen Receptors Targeting Human CytomegalovirusAyub Ali, Flavia Chiuppesi, Minh Nguyen, et al.
Plos One|August 17, 2017
Comparison of homologous and heterologous prime-boost vaccine approaches using Modified Vaccinia Ankara and soluble protein to induce neutralizing antibodies by the human cytomegalovirus pentamer complex in miceFlavia Chiuppesi, Felix Wussow, Louise Scharf, et al.
Cancer Gene Therapy|March 3, 2019
Salmonella-mediated therapy targeting indoleamine 2, 3-dioxygenase 1 (IDO) activates innate immunity and mitigates colorectal cancer growthThuy Phan, Vu H Nguyen, Marcela S D'Alincourt, et al.
Medical Microbiology and Immunology|January 16, 2008
Evaluation of recombinant modified vaccinia Ankara virus-based rhesus cytomegalovirus vaccines in rhesus macaquesYujuan Yue, Zhongde Wang, Kristina Abel, et al.
Vaccine|June 17, 2015
Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortalityElizabeth C Swanson, Pete Gillis, Nelmary Hernandez-Alvarado, et al.
Cancer Research|April 30, 2011
Enhancement of cancer vaccine therapy by systemic delivery of a tumor-targeting Salmonella-based STAT3 shRNA suppresses the growth of established melanoma tumorsEdwin R Manuel, Céline A Blache, Rebecca Paquette, et al.
Transplantation and Cellular Therapy|March 10, 2022
CMV Triplex Vaccine to Enhance Adaptive NK and T-cell Reconstitution After Autologous Hematopoietic Cell TransplantationArmin Rashidi, Corinna La Rosa, Julie Curtsinger, et al.
The Journal of Infectious Diseases|February 18, 2005
Simultaneous reconstitution of multiple cytomegalovirus-specific CD8+ cell populations with divergent functionality in hematopoietic stem-cell transplant recipientsSimon F Lacey, Joy Martinez, Ghislaine Gallez-Hawkins, et al.
Journal of Virology|November 15, 2019
Correction for Chiuppesi et al., "Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Responses against Human Cytomegalovirus in Mice"Flavia Chiuppesi, Jenny Nguyen, Soojin Park, et al.
Journal of Virology|July 27, 2018
Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in MiceFlavia Chiuppesi, Jenny Nguyen, Soojin Park, et al.
Pageof 14